NO170585C - Fremgangsmaate for fremstilling av difluorketonpeptidderivater - Google Patents

Fremgangsmaate for fremstilling av difluorketonpeptidderivater

Info

Publication number
NO170585C
NO170585C NO862269A NO862269A NO170585C NO 170585 C NO170585 C NO 170585C NO 862269 A NO862269 A NO 862269A NO 862269 A NO862269 A NO 862269A NO 170585 C NO170585 C NO 170585C
Authority
NO
Norway
Prior art keywords
difluorcoetone
procedure
preparation
peptide derivatives
derivatives
Prior art date
Application number
NO862269A
Other languages
English (en)
Norwegian (no)
Other versions
NO862269D0 (no
NO170585B (no
NO862269L (no
Inventor
Diane Amy Trainor
Mark Morris Stein
Original Assignee
Ici America Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858514438A external-priority patent/GB8514438D0/en
Priority claimed from GB858514436A external-priority patent/GB8514436D0/en
Priority claimed from GB858514440A external-priority patent/GB8514440D0/en
Application filed by Ici America Inc filed Critical Ici America Inc
Publication of NO862269D0 publication Critical patent/NO862269D0/no
Publication of NO862269L publication Critical patent/NO862269L/no
Publication of NO170585B publication Critical patent/NO170585B/no
Publication of NO170585C publication Critical patent/NO170585C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K5/00Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06Dipeptides
    • C07K5/06191Dipeptides containing heteroatoms different from O, S, or N
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/18Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
NO862269A 1985-06-07 1986-06-06 Fremgangsmaate for fremstilling av difluorketonpeptidderivater NO170585C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB858514438A GB8514438D0 (en) 1985-06-07 1985-06-07 Selected difluoro ketone dipeptide derivatives
GB858514436A GB8514436D0 (en) 1985-06-07 1985-06-07 Selected difluoro derivatives
GB858514440A GB8514440D0 (en) 1985-06-07 1985-06-07 Difluoro ketone tripeptide derivatives

Publications (4)

Publication Number Publication Date
NO862269D0 NO862269D0 (no) 1986-06-06
NO862269L NO862269L (no) 1986-12-08
NO170585B NO170585B (no) 1992-07-27
NO170585C true NO170585C (no) 1992-11-04

Family

ID=27262698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO862269A NO170585C (no) 1985-06-07 1986-06-06 Fremgangsmaate for fremstilling av difluorketonpeptidderivater

Country Status (16)

Country Link
US (1) US4880780A (es)
EP (1) EP0204571B1 (es)
JP (1) JPH07116159B2 (es)
AT (1) ATE71934T1 (es)
AU (1) AU594683B2 (es)
DE (1) DE3683541D1 (es)
DK (1) DK267686A (es)
ES (4) ES8801305A1 (es)
FI (1) FI86859C (es)
GR (1) GR861488B (es)
HU (1) HU208438B (es)
IE (1) IE59146B1 (es)
IL (1) IL79049A0 (es)
NO (1) NO170585C (es)
NZ (1) NZ216437A (es)
PT (1) PT82724B (es)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
US5496927A (en) * 1985-02-04 1996-03-05 Merrell Pharmaceuticals Inc. Peptidase inhibitors
GB8613703D0 (en) * 1986-06-05 1986-07-09 Ici America Inc Difluoro peptide compounds
DE3782191T2 (de) * 1986-06-05 1993-02-25 Ici America Inc Difluorketoverbindungen.
GB8809316D0 (en) * 1987-05-11 1988-05-25 Ici America Inc Heterocyclic ketones
EP0371179A1 (en) * 1988-10-28 1990-06-06 Merrell Dow Pharmaceuticals Inc. Novel analogs of peptidase substrates
EP0369391A3 (en) * 1988-11-15 1991-09-25 Boehringer Ingelheim Pharmaceuticals Inc. N-substituted amides
GB8910547D0 (en) * 1989-05-08 1989-06-21 Ici America Inc Substituted ketones
US5221665A (en) * 1989-10-27 1993-06-22 Boehringer Ingelheim Pharmaceuticals, Inc. N-substituted amides
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
WO1992020357A1 (en) * 1991-05-23 1992-11-26 Merrell Dow Pharmaceuticals Inc. Inhibitors of cathepsin g and elastase for preventing connective tissue degradation
US5478811A (en) * 1991-08-22 1995-12-26 Merrell Dow Pharmaceuticals Inc. Orally-active elastase inhibitors
US5714470A (en) * 1991-08-22 1998-02-03 Merrell Pharmaceuticals, Inc. Orally-active elastase inhibitors
US5486529A (en) * 1992-04-16 1996-01-23 Zeneca Limited Certain pyridyl ketones for treating diseases involving leukocyte elastase
IL108031A0 (en) * 1992-12-22 1994-04-12 Procter & Gamble Difluoro pentapeptide derivatives and pharmaceutical compositions containing them
ES2161293T3 (es) * 1994-06-02 2001-12-01 Merrell Pharma Inc Derivados de enol acilados como profarmacos de inhibidores de la elastasa.
NZ284766A (en) * 1994-06-02 1998-06-26 Merrell Pharma Inc Perfluoro amino ketones; medicaments as elastase inhibitors
DE69531459T2 (de) * 1994-06-02 2004-06-24 Aventis Pharmaceuticals Inc. Elatase-inhibitoren
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6673784B1 (en) 1996-03-19 2004-01-06 G. D. Searle & Co. Electrophilic ketones for the treatment of herpesvirus infections
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
PL194025B1 (pl) 1996-10-18 2007-04-30 Vertex Pharma Inhibitory proteaz serynowych, a zwłaszcza proteazy wirusa NS3 zapalenia wątroby C, kompozycja farmaceutyczna i zastosowanie inhibitorów proteaz serynowych
SV2003000617A (es) * 2000-08-31 2003-01-13 Lilly Co Eli Inhibidores de la proteasa peptidomimetica ref. x-14912m
MY148123A (en) 2003-09-05 2013-02-28 Vertex Pharma Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
US7964624B1 (en) 2005-08-26 2011-06-21 Vertex Pharmaceuticals Incorporated Inhibitors of serine proteases
AR055395A1 (es) 2005-08-26 2007-08-22 Vertex Pharma Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
EP1991229A2 (en) 2006-02-27 2008-11-19 Vertex Pharmaceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
CA2646229A1 (en) * 2006-03-16 2007-09-27 Vertex Pharmaceuticals Incorporated Deuterated hepatitis c protease inhibitors
MX2009005252A (es) * 2006-11-17 2009-05-28 Abbott Lab Aminopirrolidinas como antagonistas del receptor de quimiocina.
AP2009004960A0 (en) 2007-02-27 2009-08-31 Vertex Pharma Co-crystals and pharmaceutical compositions comprising the same
CA2679426A1 (en) 2007-02-27 2008-09-04 Luc Farmer Inhibitors of serine proteases
EP2436682A1 (en) 2007-08-30 2012-04-04 Vertex Pharmceuticals Incorporated Co-crystals and pharmaceutical compositions comprising the same
PE20121647A1 (es) 2009-08-29 2012-12-31 Abbvie Inc Proteinas terapeuticas de union a dll4
RU2605928C2 (ru) 2010-03-02 2016-12-27 Эббви Инк. Терапевтические dll4-связывающие белки
BR112013002578A2 (pt) 2010-08-03 2019-05-14 Abbvie Inc. imunoglobinas de domínio variável duplo e usos das mesmas
MY194330A (en) 2012-11-01 2022-11-28 Abbvie Inc Anti-dll4/vegf dual variable domain immunoglobulin and uses thereof
US10093733B2 (en) 2014-12-11 2018-10-09 Abbvie Inc. LRP-8 binding dual variable domain immunoglobulin proteins
TW201710286A (zh) 2015-06-15 2017-03-16 艾伯維有限公司 抗vegf、pdgf及/或其受體之結合蛋白
MX2021015894A (es) * 2019-07-01 2022-02-03 Basf Se Peptidos acetales para estabilizar enzimas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE787249A (fr) 1971-08-05 1973-02-05 Squibb & Sons Inc Derives amino d'acides pyrazolopyridine carboxyliques, leurs esters et les sels de ces composes, ainsi que leurs procedes de preparation
US3935280A (en) 1975-01-10 1976-01-27 Aldrich-Boranes, Inc. Reduction of amino acids in the presence of boron trifluoride
US4277395A (en) * 1980-06-16 1981-07-07 Richardson-Merrell Inc. Novel enzyme inhibitors
DE3481913D1 (de) 1983-04-27 1990-05-17 Ici America Inc Prolin-derivate.
US4518528A (en) * 1983-05-19 1985-05-21 Rasnick David W α Amino fluoro ketones
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives

Also Published As

Publication number Publication date
JPS6253951A (ja) 1987-03-09
ES557735A0 (es) 1988-05-01
ES557733A0 (es) 1988-09-01
FI86859B (fi) 1992-07-15
DK267686D0 (da) 1986-06-06
ATE71934T1 (de) 1992-02-15
HUT40811A (en) 1987-02-27
AU594683B2 (en) 1990-03-15
EP0204571A3 (en) 1988-09-21
ES8900051A1 (es) 1988-11-16
AU5845486A (en) 1986-12-18
DK267686A (da) 1986-12-08
NO862269D0 (no) 1986-06-06
NO170585B (no) 1992-07-27
HU208438B (en) 1993-10-28
FI862434A (fi) 1986-12-08
IE861513L (en) 1986-12-07
EP0204571A2 (en) 1986-12-10
FI862434A0 (fi) 1986-06-06
ES555826A0 (es) 1987-12-16
IE59146B1 (en) 1994-01-12
DE3683541D1 (de) 1992-03-05
ES8802619A1 (es) 1988-09-01
IL79049A0 (en) 1986-09-30
JPH07116159B2 (ja) 1995-12-13
US4880780A (en) 1989-11-14
ES8801305A1 (es) 1987-12-16
ES557734A0 (es) 1988-11-16
PT82724A (en) 1986-07-01
NO862269L (no) 1986-12-08
FI86859C (fi) 1992-10-26
EP0204571B1 (en) 1992-01-22
NZ216437A (en) 1990-06-26
GR861488B (en) 1986-09-05
ES8802321A1 (es) 1988-05-01
PT82724B (pt) 1988-12-15

Similar Documents

Publication Publication Date Title
NO170585C (no) Fremgangsmaate for fremstilling av difluorketonpeptidderivater
ES8706169A1 (es) Procedimiento para preparar peptidos trifluormetilcetona-sustituidos.
FI912328A0 (fi) Peptidfoerening och dess framstaellning.
FI915819A (fi) Hiv- proteas-inhibitorer.
NO910340L (no) Topiske preparater for behandling av menneskenegler.
NO980848D0 (no) Piperazinoderivater som neurokininantagonister
GR920100570A (el) Παραγωγα 3(2η)-πυριδαζινονης και μεθοδος για την παρασκευη τους.
NO20000771L (no) Anvendelse av fankinon for behandling av Alzheimers sykdom
ATE90359T1 (de) Peptide.
DK0505400T3 (da) N-substituerede naphthalimider, deres fremstilling og anvendelse
DK0552106T3 (da) Peptider med antagonistaktivitet over for bradykinin
RU93047049A (ru) Новые производные фосфолипидов
SE9000793D0 (sv) Sdk-peptider,foerfarande foer framstaellning daerav och terapeutiska kompositioner innehaallande dem
RU93045696A (ru) Ингибиторы протеазы вируса иммунодефицита человека, полезные для лечения спида
GEP19991605B (en) Inhibitor, Its Obtaining and Use
RU93055681A (ru) Ингибиторы вич-протеазы, способ их получения, их использование в фармкомпозициях